IVI RMA Completes Acquisition of North American Operations of Eugin Group, Including Boston IVF and TRIO

BASKING RIDGE, N.J.–(BUSINESS WIRE)–IVI RMA, one of the largest reproductive medicine groups in the world, today announced that it has completed the acquisition of North American Operations of Eugin Group, consisting of the Boston IVF fertility network and Toronto-based TRIO. The strategic additions further IVI RMA market leadership in North America and reinforce the company’s commitment to providing evidence-based fertility solutions with the greatest chance of success to the greatest number of patients.

“We have an enormous opportunity to put our collective experience to work in a dynamic and rapidly growing segment of the healthcare market,” said Javier Sanchez Prieto, CEO of IVI RMA. “The companies’ complementary strengths and shared vision position us to bring the best fertility science to more markets across North America.”

The acquisition adds over 600 employees across 13 labs and 32 satellite offices to IVI RMA’s network of 10 labs and 29 satellites in North America, bringing the organization’s total headcount to more than 4,400 globally. In addition, Boston IVF brings multiple academic affiliations, including Harvard Medical School, Dartmouth Hitchcock Medical School, Boston University Medical Center, and Tufts Medical Center, among others. The acquired businesses will continue to operate under their existing brands.

“We are excited to officially welcome Boston IVF, its partner clinics, and TRIO to the IVI RMA network,” added Lynn Mason, CEO of IVI RMA America. “While these practices will continue to operate under their current brands, we see significant opportunities for collaboration that will enhance our operations and deliver an even better experience to our parents and patients.”

“Our entire team at Boston IVF and colleagues at TRIO are thrilled to join the global network of IVI RMA,” said David Stern, CEO of Boston IVF. “We are eager to leverage our combined resources to enable the next phase of shared growth and make the IVI RMA network an even more formidable player in North American fertility.”

“Joining with Boston IVF and Trio strengthens our ability to deliver a world-class patient experience through personalized care,” added Thomas A. Molinaro, M.D., Chief Medical Officer of IVI-RMA America. “We are excited to help more patients achieve their dreams of growing their family.”

“We’re eager to bring our cutting-edge science and connections with leading academic institutions to one of the largest reproductive medicine groups in the world,” said Michael Alper, M.D., Medical Director and President of Boston IVF. “Together with IVI RMA, we will continue to pave the way for breakthroughs in fertility care.”

About IVI RMA Global

IVI RMA is one of the world’s leading Reproductive Medicine groups. It is committed to providing evidence-based fertility solutions with the greatest chance of success in the shortest time necessary to patients seeking treatment anywhere in the world. IVI RMA employs more than 4,400 people across +150 locations in 14 countries. The group maintains a team of highly trained physicians as well as renowned scientists and researchers, aligned with its vision of pioneering in the field of Reproductive Medicine. Learn more at

About Boston IVF

Boston IVF is one of the largest and most experienced fertility networks in the United States, with more than 150,000 babies born since 1986. Founded as one of the nation’s first private practice IVF centers, the Boston IVF network has grown to include over 30 reproductive endocrinologists across 30 centers throughout Massachusetts, Maine, New Hampshire, Rhode Island, New York, Delaware, Idaho, Indiana, North Carolina, Ohio, and Utah. A renowned innovator of reproductive technologies, advanced protocols, and cutting-edge research, Boston IVF has achieved numerous “firsts” in reproductive care. Its scientific and research arm continues to pave the way for breakthroughs in fertility care, and its accredited REI Fellowship Program has graduated numerous reproductive endocrinologists as part of its mission to train the next generation of fertility experts.

About TRIO

TRIO is Canada’s leading fertility clinic with 10 locations across Ontario and more than 40 years of experience. TRIO is proud to have the largest in-house fertility medical team in Canada with 13 fertility specialists and over 45 supporting medical staff.